NO20055668L - Beta-amyloidinhibitorer og anvendelse derav - Google Patents
Beta-amyloidinhibitorer og anvendelse deravInfo
- Publication number
- NO20055668L NO20055668L NO20055668A NO20055668A NO20055668L NO 20055668 L NO20055668 L NO 20055668L NO 20055668 A NO20055668 A NO 20055668A NO 20055668 A NO20055668 A NO 20055668A NO 20055668 L NO20055668 L NO 20055668L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- amyloid
- amyloid inhibitors
- dernentia
- pugilistica
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Navigation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101202 | 2003-04-30 | ||
PCT/EP2004/004807 WO2004096845A2 (fr) | 2003-04-30 | 2004-04-29 | Inhibiteurs de beta-amyloide et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055668D0 NO20055668D0 (no) | 2005-11-30 |
NO20055668L true NO20055668L (no) | 2005-11-30 |
Family
ID=33395961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055668A NO20055668L (no) | 2003-04-30 | 2005-11-30 | Beta-amyloidinhibitorer og anvendelse derav |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070293422A1 (fr) |
EP (1) | EP1618129A2 (fr) |
JP (1) | JP2007523848A (fr) |
AU (1) | AU2004234076A1 (fr) |
CA (1) | CA2522460A1 (fr) |
NO (1) | NO20055668L (fr) |
WO (1) | WO2004096845A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5190957B2 (ja) * | 2006-04-28 | 2013-04-24 | 国立大学法人 鹿児島大学 | アミロイドβ線維化阻害ペプチド |
JP6169567B2 (ja) * | 2011-05-31 | 2017-07-26 | ハチソン バイオフィルム メディカル ソリューションズ リミテッド | 細胞集塊の分散及び脱離 |
KR102475326B1 (ko) * | 2022-01-27 | 2022-12-07 | 한국기초과학지원연구원 | 신규한 펩타이드 유사체 및 이를 포함하는 알츠하이머 병 예방 조성물 |
CN114578066B (zh) * | 2022-05-07 | 2022-08-19 | 北京第一生物化学药业有限公司 | 检测β-淀粉样蛋白的产品和方法 |
CN114594272B (zh) * | 2022-05-07 | 2022-08-23 | 北京第一生物化学药业有限公司 | 用于检测β-淀粉样蛋白的产品和方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11514333A (ja) * | 1995-03-14 | 1999-12-07 | プレーシス ファーマスーティカルズ インコーポレイテッド | アミロイドの凝集の調節剤 |
US6399584B1 (en) * | 1998-03-18 | 2002-06-04 | Institute Curie | Pharmaceutical composition containing ezrin mutated on tyrosine 353 |
ATE419273T1 (de) * | 1998-11-13 | 2009-01-15 | Cyclacel Ltd | Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3 |
US6303576B1 (en) * | 1999-04-21 | 2001-10-16 | Adherex Technologies Inc. | Compounds and methods for modulating β-catenin mediated gene expression |
GB9917724D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
WO2002062989A2 (fr) * | 2001-02-08 | 2002-08-15 | Sequitur, Inc. | Procedes de liberation activee par la lumiere de ligands a partir d'endosomes |
FR2829940A1 (fr) * | 2001-09-27 | 2003-03-28 | Synt Em | Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central |
-
2004
- 2004-04-29 AU AU2004234076A patent/AU2004234076A1/en not_active Abandoned
- 2004-04-29 WO PCT/EP2004/004807 patent/WO2004096845A2/fr active Application Filing
- 2004-04-29 CA CA002522460A patent/CA2522460A1/fr not_active Abandoned
- 2004-04-29 US US10/554,372 patent/US20070293422A1/en not_active Abandoned
- 2004-04-29 JP JP2006505384A patent/JP2007523848A/ja active Pending
- 2004-04-29 EP EP04730265A patent/EP1618129A2/fr not_active Withdrawn
-
2005
- 2005-11-30 NO NO20055668A patent/NO20055668L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2004234076A1 (en) | 2004-11-11 |
CA2522460A1 (fr) | 2004-11-11 |
EP1618129A2 (fr) | 2006-01-25 |
NO20055668D0 (no) | 2005-11-30 |
JP2007523848A (ja) | 2007-08-23 |
WO2004096845A2 (fr) | 2004-11-11 |
US20070293422A1 (en) | 2007-12-20 |
WO2004096845A3 (fr) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055668L (no) | Beta-amyloidinhibitorer og anvendelse derav | |
NO20052223L (no) | Tiazolforbindelser for behandling av neurodegenerative forstyrrelser | |
NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
NO20045137L (no) | Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens | |
KR960704839A (ko) | β-아밀로이드 단백질 생성 억제제(Inhibitors of β-amyloid protein production) | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20053263L (no) | Hydroksyetylaminderivater for behandling av Alzheimers sykdom. | |
NO20045281L (no) | Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer | |
NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
NO20050701L (no) | 4-pyrrolidino-fenyl-benzyleter derivater | |
ATE458753T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
NO20053855D0 (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
CA2188817A1 (fr) | Inhibiteur de l'angiogenese | |
DE573603T1 (de) | Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g. | |
NO20052272L (no) | CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom | |
Kida et al. | Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
NO20070665L (no) | Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer | |
ZA200701798B (en) | Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors | |
NO20053237L (no) | Azapeptider. | |
NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
CY1114209T1 (el) | Φαρμακευτικες και καλλυντικες συνθεσεις που περιλαμβανουν plgf-1 | |
HUP0000386A1 (hu) | Adamantánaminok és szerkezetileg hasonló vegyületek alkalmazása borna-betegséget okozó vírus leküzdésére, valamint kedélybetegségek és más, a borna-betegséget okozó vírusfertőzéssel kapcsolatos zavarok megelőzésére és kezelésére |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |